Tags

Type your tag names separated by a space and hit enter

Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease.
ACG Case Rep J. 2016 Jan; 3(2):107-8.AC

Abstract

Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.

Authors+Show Affiliations

Department of Medicine, Division of Gastroenterology, University of Miami, Leonard M. Miller School of Medicine, Miami, FL.Department of Medicine, Division of Gastroenterology, University of Miami, Leonard M. Miller School of Medicine, Miami, FL.

Pub Type(s)

Case Reports

Language

eng

PubMed ID

26958561

Citation

Barkin, Jodie A., and Amar R. Deshpande. "Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease." ACG Case Reports Journal, vol. 3, no. 2, 2016, pp. 107-8.
Barkin JA, Deshpande AR. Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease. ACG Case Rep J. 2016;3(2):107-8.
Barkin, J. A., & Deshpande, A. R. (2016). Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease. ACG Case Reports Journal, 3(2), 107-8. https://doi.org/10.14309/crj.2016.15
Barkin JA, Deshpande AR. Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease. ACG Case Rep J. 2016;3(2):107-8. PubMed PMID: 26958561.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease. AU - Barkin,Jodie A, AU - Deshpande,Amar R, Y1 - 2016/01/20/ PY - 2015/08/25/received PY - 2015/12/13/accepted PY - 2016/3/10/entrez PY - 2016/3/10/pubmed PY - 2016/3/10/medline SP - 107 EP - 8 JF - ACG case reports journal JO - ACG Case Rep J VL - 3 IS - 2 N2 - Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition. SN - 2326-3253 UR - https://www.unboundmedicine.com/medline/citation/26958561/Ustekinumab_for_Successful_Treatment_of_Refractory_Esophageal_Crohn's_Disease_ L2 - https://doi.org/10.14309/crj.2016.15 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.